Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.00
Bid: 37.00
Ask: 39.00
Change: -1.00 (-2.56%)
Spread: 2.00 (5.405%)
Open: 39.00
High: 39.00
Low: 38.00
Prev. Close: 39.00
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: YouGov, Sareum and InterQuest...

Tue, 07th Aug 2012 11:25

Environmental Recycling Technologies, which owns the rights to the Powder Impression Moulding (PIM) process which is capable of converting mixed waste plastics into commercially viable products, has confirmed that its US parent application, entitled 'Process for Forming Plastic, Apparatuses for Forming Plastic and Articles Made Therefrom', has been granted by the US Patent Office. This is ERT's core patent in the US for the PIM process. Sareum, a specialist cancer drug discovery business, has said it notes the recent significant rise in its share price and has confirmed that "advanced stages of negotiations are taking place with a potential licencing partner". It added these "may or may not lead to a licencing agreement regarding one of the company's research programmes". Shares were up 184% on Tuesday, equal to 1.15p. The stock has gained 42% over the past year, and 163% in the past month. YouGov, the online market research firm, is anticipating that its operating profit will be in line with expectations with second half revenue similar to that achieved in the first half, reflecting the firm's focus on profitability in the German business and the expected end to a long-term contract in Iraq. The firm said its balance sheet remains strong with cash at July 31st of around £7.0m. TClarke, a building services company, reported a decline in pre-tax profit for the half year at £0.5m (2011: £1.4m) on revenues of £90.7m (2011: £92.6m), with the profit margin also lower at 0.5% compared to 1.5% the previous year. Basic earnings per share dropped from 2.38p to 0.79p, while net cash climbed £0.1m to £0.7m. The interim dividend was maintained at 1p per share. The firm blamed a lack of confidence across the sector for the declines and said that with a number of projects due to begin shortly it is confident of significant revenue progress in the second half. Shares in InterQuest Group, a specialist information technology recruitment group, took a hit after it admitted earnings before interest, tax, depreciation and amortisation are expected to be down year-on-year, in the region of £1.15m (2011: £1.86m), and warned the impact of investments and restructuring on profitability for 2012 will be around £1.6m. Trading conditions were poor in both the UK and Far East, particularly in the second quarter and particularly in the banking and finance sectors from which it derives 27% of its net fee income. This has meant profitability from investments has taken longer than anticipated. NR
More News
12 May 2015 09:37

Sareum Holdings Up As CEO Gets Ready To Present At Partnering Conference

Read more
7 May 2015 11:28

LONDON MIDDAY BRIEFING: Morrison Sales Continue To Decline

Read more
7 May 2015 10:26

WINNERS & LOSERS: Morrisons Sales Decline Sinks Shares

Read more
7 May 2015 09:19

Sareum Says Equity Swap Deal With YA Global Master Ends Early (ALLISS)

Read more
25 Feb 2015 11:32

Sareum Cautiously Optimistic As It Posts Widened First Half Loss

Read more
20 Jan 2015 08:11

Sareum Gets Further US Patent Protection For Kinase Inhibitors

Read more
10 Nov 2014 08:55

Sareum Granted European Patent For Kinase Inhibitor Compounds

Read more
14 Oct 2014 08:56

Sareum Holdings Sees Widened Loss As It Focuses On Commercialisation

Read more
1 Oct 2014 11:54

Sareum reports progress with psoriasis drug development programme

Drug development firm Sareum and its partner SRI International have reported progress with its drug development programme for the autoimmune disease psoriasis. Psoriasis can occur when the production of cytokines is not properly regulated and immune cells are consequently overly activated. The cyct

Read more
1 Oct 2014 08:06

Sareum Sees "Promising Step" In Potential Psoriasis Drug

Read more
22 Sep 2014 08:16

Sareum Granted EU Patent For CHKI Cancer Programme Invention

Read more
2 Jul 2014 07:49

Sareum Holdings Granted Japanese Patent For Kinase Inhibitors

Read more
13 Jun 2014 07:32

Sareum Holdings Raises New Money From YA Global Master

LONDON (Alliance News) - Sareum Holdings PLC Friday said it has raised GBP550,000 through a new placing and equity swap with YA Global Master SPV Ltd, money it will use for working capital and to fund its main research programmes. The specialist cancer drug company said YA Global Master ha

Read more
26 Feb 2014 15:19

UK MIDDAY BRIEFING: ITV Punished For Not Paying Out More

LONDON (Alliance News) - ITV reported higher profits and revenues for 2013 and gave a bullish outlook for 2014, but has seen its shares punished Wednesday after it failed to increase its special dividend. The television company raised its total dividend for 2013 to 3.5 pence, from 2.6 pence

Read more
26 Feb 2014 12:24

UK WINNERS & LOSERS: Contrarian Price Moves For ITV And Weir Shares

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.

-------

FTSE 100 - WINNERS

Weir Group, up 6.5%. Despite reporting a fall in profit and revenue fo

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.